Nirdharya Lab India Private Limited
Developing an end-to-end platform for microgravity research, including ground-based simulators and orbital platforms.
Website: https://www.resolutelab.in/
Cover Block
From the public record
| Field | Value |
|---|---|
| Name | Nirdharya Lab India Private Limited [TheCompanyCheck, April 2024] |
| Tagline | Developing an end-to-end platform for microgravity research, including ground-based simulators and orbital platforms. [F6S] [Uttar Pradesh Startup & Incubation, May 2026] |
| Headquarters | Bareilly, India [Uttar Pradesh Startup & Incubation, May 2026] [F6S] |
| Founded | 2024 [TheCompanyCheck, April 2024] [Uttar Pradesh Startup & Incubation, May 2026] |
| Stage | Pre-Seed [Inc42, May 2026] |
| Business Model | SaaS [F6S] |
| Industry | Deeptech [F6S] |
| Technology | Space [F6S] |
| Geography | South Asia [Uttar Pradesh Startup & Incubation, May 2026] |
| Growth Profile | Venture Scale [F6S] |
| Founding Team | Co-Founders (2) [Inc42, May 2026] |
| Funding Label | Undisclosed [F6S] [YourStory, retrieved 2026] |
Links
From the public record
- LinkedIn: https://in.linkedin.com/company/resolute-lab
- F6S: https://www.f6s.com/company/resolute-lab-india
- Crunchbase: https://www.crunchbase.com/organization/resolute-lab-india
- YourStory: https://yourstory.com/companies/resolute-lab-india
- Instagram: https://www.instagram.com/entrepreneurs_society__/p/DFQS-DkSUim/
The Short Version
PUBLIC Nirdharya Lab India Private Limited, operating as Resolute Lab India, is building a microgravity research platform that pairs a ground-based simulator with a planned orbital experimentation stack, a concept that merits attention because it targets a real bottleneck in life-science access to space from an Indian base of operations [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase] [F6S]. The company appears to have been founded in 2024 in Bareilly, India, and the clearest public record today still frames it as a prototype-stage venture rather than a scaled commercial business, which keeps the story early but legible [TheCompanyCheck, April 2024] [Uttar Pradesh Startup & Incubation, May 2026] [Inc42, May 2026].
The product thesis is unusually broad for this stage: management materials describe an end-to-end offering that starts with a clinostat for ground testing and extends to payload development, launch integration, experiment slots in orbit, re-entry, and reporting, with the stated aim of letting researchers screen experiments on Earth before committing them to flight [Uttar Pradesh Startup & Incubation, May 2026] [F6S]. If that sequencing works in practice, the differentiation rests less on a single hardware asset and more on workflow integration across pre-flight validation and orbital execution, although that remains a company-described model rather than a publicly verified operating system at scale [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase].
Public evidence on the team is still thin. Arjit Saxena is consistently identified as founder, and RocketReach lists him as Founder and CEO; Inc42 indicates there is one additional co-founder, though the accessible public record here does not name that person [F6S] [RocketReach] [Inc42, May 2026]. Supporting team signals exist, including profiles for a visiting research scholar and an electronic systems designer, but the available sources do not yet establish a fully documented leadership bench or prior company-building track record in public filings or major coverage [RocketReach] [LinkedIn].
On capitalization, the record is notably sparse. Inc42 classifies the company as bootstrapped, while F6S associates it with AIC T-Hub SpaceTech Program Cohort 2 and names T-Hub in the investor field; absent disclosed terms, that should be read as ecosystem validation rather than confirmed institutional financing [Inc42, May 2026] [F6S] [The Hindu]. The business model is described as platform-as-a-service, with revenue intended from rentals, experiment slots, payload development, and mission support, but investors should watch over the next 12 to 18 months for evidence of named research customers, completed prototype milestones, and any disclosed funding that moves the company beyond concept credibility into repeatable execution [Uttar Pradesh Startup & Incubation, May 2026].
Unconfirmed -- This section relies materially on company profiles and a government startup directory, with limited independent corroboration from Inc42, RocketReach, and corporate registry sources.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Business Model | SaaS |
| Industry / Vertical | Deeptech |
| Technology Type | Space |
| Geography | South Asia |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Undisclosed |
The Company in Brief
PUBLIC
The public record on Nirdharya Lab India Private Limited is still thin, but the basic corporate outline is clear enough to anchor the story. The company was incorporated in India in 2024, is headquartered in Bareilly, and operates publicly under the Resolute Lab India brand, according to state filing aggregators and startup databases [TheCompanyCheck, April 2024] [Falcon Ebiz, April 2024] [Crunchbase].
What the company says it is building is more ambitious than the current paper trail. Crunchbase describes Resolute Lab India as developing microgravity research platforms for biotechnology, pharmaceuticals, cancer research, and materials science, with services that include miniaturized, remotely controlled laboratory systems for experiments in low Earth orbit and related ground-based environments [Crunchbase]. That framing is consistent with the legal entity's recent vintage: the company appears to be at an early formation stage rather than a scaled commercial operator [TheCompanyCheck, April 2024] [Falcon Ebiz, April 2024].
The milestone sequence visible from public sources is short but directionally useful. Incorporation appears in April 2024 through company-record services [TheCompanyCheck, April 2024] [Falcon Ebiz, April 2024]. By 2026, Crunchbase had a live company profile for Resolute Lab India, indicating the venture had begun to present itself outwardly as a space-biotech infrastructure startup rather than merely a newly formed private entity [Crunchbase].
Confirmed across multiple sources -- Confirmed by Crunchbase and Indian company-record sources, with chronology corroborated by TheCompanyCheck and Falcon Ebiz.
What They Have Built
MIXED
The product story is straightforward in outline and thin in verification. Public profiles describe Nirdharya Lab India, operating as Resolute Lab India, as building an end-to-end platform for microgravity research, with the current concept spanning both ground-based simulation and an orbital experimentation layer [F6S] [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase, retrieved 2026]. The most specific public description comes from the Uttar Pradesh startup directory, which says the platform combines a ground-based microgravity simulator, described as a clinostat, with an in-development orbital research platform that includes re-entry capability [Uttar Pradesh Startup & Incubation, May 2026].
The intended workflow appears to center on screening biological experiments on Earth before sending selected payloads to orbit, a sequencing that, if executed, could make space-based life-science research more usable for pharma, biotech, and academic labs [Uttar Pradesh Startup & Incubation, May 2026]. Across public sources, the company also describes services around payload development, launch integration, protocol design, data reporting, mission integration, and remotely controlled miniaturized laboratory systems for low Earth orbit experiments, but these claims remain descriptive rather than demonstrated by a verified deployment, customer case study, or public demo in the supplied evidence [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase, retrieved 2026].
What matters at this stage is less the breadth of the claimed stack than the maturity gap inside it. The same government directory that provides the clearest product detail labels the venture as being at the prototype stage as of May 2026, which suggests the orbital and re-entry elements should be read as development plans rather than commercially proven infrastructure [Uttar Pradesh Startup & Incubation, May 2026]. No public source in the provided materials substantiates the technical architecture, flight readiness, or operating performance of the platform, and there are no job-posting based stack inferences available because no open roles were surfaced in the research set [F6S] [LinkedIn, retrieved 2026].
Unconfirmed -- Product scope is described across F6S, Crunchbase, and the Uttar Pradesh startup directory, but the material technical claims remain largely company-supplied and unverified by public demos, deployments, or independent technical reporting.
Market Size and Demand
PUBLIC
The market matters because Resolute Lab India is trying to sell into two expensive, slow-moving procurement environments at once, life-science R&D and space access, and timing matters more here than category storytelling [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase].
Public evidence does not support a direct TAM, SAM, or SOM model for this company’s specific niche, and that absence is material. The available sources describe a proposed microgravity research platform serving biotechnology, pharmaceuticals, cancer research, materials science, academic laboratories, and national research programs, but they do not attach market-size estimates from a named third-party report [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase]. In practice, the addressable market should be read as the overlap between contract research tools for life sciences and access infrastructure for in-orbit experimentation, rather than as a standalone, already-measured category.
Demand, if it develops, is likely to be driven by the company’s stated effort to reduce the cost and complexity of space biology workflows. The central claim in the public materials is not simply orbital access, but a screening stack in which researchers can test biological experiments first on a ground-based clinostat and then move selected work to an orbital platform with re-entry capability [Uttar Pradesh Startup & Incubation, May 2026]. That is a sensible commercial framing because it aligns with how research budgets are usually released, in stages, and because it offers buyers a lower-commitment entry point than a full orbital experiment.
The closest adjacent markets are easier to identify than the core market itself. On one side are laboratory tools, simulation systems, and contract research services sold to pharma, biotech, and academic labs; on the other are payload integration, launch brokerage, and hosted in-space research services sold into government and institutional programs [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase]. For an early company, those adjacent markets matter because buyer expectations will likely be imported from them: researchers may compare the ground product to existing lab equipment budgets, while national programs and advanced R&D groups may compare the orbital offering to alternative hosted-payload pathways.
Regulatory and macro conditions cut both ways. The positive signal is institutional: the company appears in the Uttar Pradesh startup directory and participated in the AIC T-Hub SpaceTech Program Cohort 2, which suggests some alignment with India’s current push to widen the domestic spacetech base beyond launch and satellites [Uttar Pradesh Startup & Incubation, May 2026] [F6S] [The Hindu]. The constraint is that any commercial microgravity stack touching orbital experimentation, payload integration, and re-entry services sits inside a market where technical validation, mission assurance, and program timing usually move more slowly than startup fundraising cycles.
| Market lens | Publicly supported claim | Source |
|---|---|---|
| Core use case | Platform aimed at microgravity research with ground and orbital components | [Uttar Pradesh Startup & Incubation, May 2026] |
| Target demand pool | Pharma, biotech, academic laboratories, and national research programs are named target users | [Uttar Pradesh Startup & Incubation, May 2026] |
| Adjacent budget pool | Services include payload development, launch integration, re-entry, protocol design, and data reporting | [Uttar Pradesh Startup & Incubation, May 2026] |
| Applied domains | Biotechnology, pharmaceuticals, cancer research, and materials science are named application areas | [Crunchbase] |
The table shows why market-definition discipline matters here. The public record supports a real use case and a plausible customer set, but it does not yet support a quantified market map, which means the next diligence step is customer-budget validation rather than top-down sizing.
Unconfirmed -- This section relies primarily on company-profile and government-directory descriptions of target customers, use cases, and service scope, with no third-party market-sizing report or independently verified commercial demand data in the cited record.
Who Else Is Fighting for This
MIXED The company is positioning itself against a broader stack of microgravity-research alternatives rather than against a clearly disclosed set of direct startup peers, which makes the competitive question less about feature parity and more about whether researchers will buy an integrated workflow from a prototype-stage entrant [Uttar Pradesh Startup & Incubation, May 2026] [F6S] [Crunchbase].
The nearest public map breaks into three segments. First are institutional and government research pathways, which already give life-science researchers routes into microgravity experimentation through established national programs and academic collaborations, although no such counterparties are named in the company materials reviewed here [Uttar Pradesh Startup & Incubation, May 2026]. Second are ground-based simulation tools, where Resolute Lab India says it is developing a clinostat to let customers screen experiments before any orbital deployment [Uttar Pradesh Startup & Incubation, May 2026]. Third are orbital research-service providers and payload integrators, where the company says it intends to offer experiment slots, payload development, launch integration, re-entry, and reporting as a bundled service [Uttar Pradesh Startup & Incubation, May 2026]. On the public record, that makes the relevant competition a mix of incumbent research infrastructure, single-point hardware vendors, and mission-integration specialists rather than a disclosed set of Indian venture-backed peers.
Its edge today appears conceptual rather than operational. The clearest differentiator in the sources is the proposed pairing of a ground simulator with an in-development orbital platform, which could reduce experiment-selection risk if researchers can validate protocols on Earth before paying for flight access [Uttar Pradesh Startup & Incubation, May 2026]. That is a sensible product thesis, particularly for biotechnology and pharmaceutical users that care about failed-run economics, but the advantage is still perishable because the public evidence does not yet show named customers, proprietary datasets, regulatory approvals, or a deployed flight system that would make switching difficult [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase] [Inc42, May 2026].
The exposure is easier to see than the moat. T-Hub is named through program participation and as an investor on F6S, which may help with early ecosystem access, but accelerator affiliation is not the same thing as owning a distribution channel or having secured launch capacity [F6S] [The Hindu]. More broadly, any incumbent with existing customer trust, lab validation history, or launch relationships would have an advantage over a prototype-stage startup if buyers decide they prefer specialist vendors over a full-stack newcomer. The public materials also do not establish a named competitor that Resolute Lab India is already displacing, which usually means the market narrative is still ahead of proven market share [Inc42, May 2026] [Uttar Pradesh Startup & Incubation, May 2026].
The most plausible 18-month scenario is a sorting process between infrastructure owners and concept builders. Resolute Lab India is the likely winner if researchers in India increasingly want a domestic pre-flight testing and mission-design layer, and if the clinostat becomes a real entry product that converts into paid orbital demand [Uttar Pradesh Startup & Incubation, May 2026]. Resolute Lab India is also the likely loser if the orbital component remains developmental while customers continue to procure through established institutional channels or narrower service providers, because in that case the integrated-stack argument stays theoretical and the company risks being compared against better-capitalized substitutes on execution rather than vision [Uttar Pradesh Startup & Incubation, May 2026] [F6S] [Inc42, May 2026].
Opportunity
PUBLIC
If execution holds, the prize here is not a narrow research-tool business but a control point in how Indian and, over time, global life-science teams design, de-risk, and run microgravity experiments across ground and orbital environments [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase].
The headline opportunity is straightforward: become the default operating layer for microgravity research coming out of India, then sell that stack to biotech, pharma, academic labs, and national research programs that want one vendor spanning experiment design, ground simulation, flight access, and data reporting [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase]. That is still an early claim, and most of the evidence is company-supplied or directory-level rather than independently validated. Still, the shape of the offer is more substantial than a single-point product. Public descriptions point to a combined system of a ground-based clinostat, an in-development orbital platform with re-entry capability, and paid services around payload development, mission integration, and reporting [Uttar Pradesh Startup & Incubation, May 2026]. If that full workflow is built, the company would sit closer to infrastructure than to a one-off instrument vendor.
The reason that outcome is reachable rather than purely aspirational is that the company is not presenting microgravity access as an isolated launch-service problem. Its stated wedge is pre-flight screening on Earth before committing selected biological experiments to orbit, which addresses cost, iteration speed, and protocol risk in one motion [Uttar Pradesh Startup & Incubation, May 2026]. The May 2026 government startup profile also places the venture at prototype stage, which at minimum suggests the concept has advanced beyond an idea-stage description and into a build phase, even if commercial proof remains unverified [Uttar Pradesh Startup & Incubation, May 2026].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| India-first microgravity stack | Resolute Lab India becomes the default domestic platform for early microgravity experiment design and validation, serving universities, biotech teams, and public research programs before broader international expansion | A working clinostat-based workflow and repeat use by Indian research institutions or national programs | The company already describes those buyer groups explicitly and positions the ground simulator as the first step before orbital deployment [Uttar Pradesh Startup & Incubation, May 2026] |
| Full-service orbital research broker | The company pairs its ground platform with payload development, launch integration, re-entry, and reporting, capturing more revenue per program than a tool-only provider | Launch of the in-development orbital platform or a credible external mission-integration partnership | Public materials describe a broader service bundle, including experiment slots, payload development, launch integration, re-entry services, and data reporting [Uttar Pradesh Startup & Incubation, May 2026] |
| Life-science workflow platform | The business standardizes protocols and data outputs across biotech, pharma, cancer research, and materials science users, creating a software-and-services layer that customers reuse across studies | Successful early projects in one or two high-value research verticals that demonstrate repeatable protocol design and reporting | Crunchbase describes the company as building microgravity research platforms for biotechnology, pharmaceuticals, cancer research, and materials science, with remotely controlled lab systems for low Earth orbit and related ground environments [Crunchbase] |
The scenarios above all depend on one common feature: the company is trying to compress a fragmented workflow into one procurement decision. That matters because a customer that starts with ground-based simulation can plausibly expand into payload design, mission integration, and orbital experiment execution without changing vendors, if the technical quality is good enough [Uttar Pradesh Startup & Incubation, May 2026].
What compounding looks like here is less a classic consumer network effect and more an infrastructure flywheel. One completed experiment can produce validated protocols, operating know-how, and data-handling routines that make the next experiment cheaper to scope and easier to sell, particularly if the same customer base values continuity from Earth-based testing to orbital deployment [Uttar Pradesh Startup & Incubation, May 2026]. If the company can accumulate a library of repeatable microgravity workflows by vertical, for example cell biology, pharma formulation, or materials science, switching costs could rise even without a large software footprint, because the value would sit in proven process and integrated execution rather than in hardware alone [Crunchbase] [Uttar Pradesh Startup & Incubation, May 2026].
There is an early distribution signal, albeit a modest one. F6S associates the company with AIC T-Hub SpaceTech Program Cohort 2 and names T-Hub in connection with the business, which may improve access to technical mentors, ecosystem partners, and future pilot pathways, though it should not be read as proof of commercial traction or institutional financing [F6S] [The Hindu]. For a company this early, ecosystem proximity can matter because buyers in spacetech and life sciences often require trust, coordination, and long sales cycles before any recurring revenue appears.
The size of the win is hard to anchor precisely because no credible market-size figure or clean public comparable is present in the source set. Even so, the upside case can be framed in company-shape terms. If the "full-service orbital research broker" scenario plays out, this could become a high-value deeptech infrastructure company selling a mix of software, hardware access, and mission services into research budgets that are typically larger and stickier than standard lab-tool subscriptions (scenario, not a forecast) [Uttar Pradesh Startup & Incubation, May 2026] [Crunchbase]. The ceiling rises further if Resolute Lab India becomes the Indian default for microgravity life-science workflows, because that would place it at a scarce intersection of spacetech, biotech tooling, and research infrastructure, where category leaders often earn strategic value beyond near-term revenue. Public evidence does not yet support a numeric valuation range, but it does support the outline of a business that could matter if it proves the integrated model.
Unconfirmed -- This section relies primarily on company and directory descriptions from Uttar Pradesh Startup & Incubation, F6S, and Crunchbase, with limited independent corroboration from The Hindu on program participation.
Sources
From the public record
[TheCompanyCheck, April 2024] Nirdharya Lab India Private Limited - FY 2026 Profile | https://www.thecompanycheck.com/company/nirdharya-lab-india-private-limited/U30304UP2024PTC200456
[F6S] RESOLUTE LAB INDIA | https://www.f6s.com/company/resolute-lab-india
[Uttar Pradesh Startup & Incubation, May 2026] Nirdharya Lab India Pvt Ltd Uttar Pradesh, Bareilly | https://www.startinup.up.gov.in/demo/Welcome/startup_user_details/Mzk1NzE=
[Inc42, May 2026] Resolute Lab India - A Health Tech Bootstrapped Company Based Out Of Bareilly | https://inc42.com/company/resolute-lab-india/
[YourStory, retrieved 2026] Resolute Lab India Company Profile Funding & Investors | https://yourstory.com/companies/resolute-lab-india
[Crunchbase] resolute lab india - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/resolute-lab-india
[RocketReach] Resolute Lab India Management Team | Org Chart | https://rocketreach.co/resolute-lab-india-management_b70fae80c4e9f1d5
[LinkedIn, retrieved 2026] Resolute Lab India | LinkedIn | https://in.linkedin.com/company/resolute-lab
[Falcon Ebiz, April 2024] NIRDHARYA LAB INDIA PRIVATE LIMITED HAVING CIN U30304UP2024PTC200456 IS 2 YEARS, 1 MONTHS & 9 DAYS OLD PRIVATE COMPANY at Falcon Ebiz | https://www.falconebiz.com/company/NIRDHARYA-LAB-INDIA-PRIVATE-LIMITED-U30304UP2024PTC200456
[The Hindu] AIC T-Hub spacetech accelerator cohort with 17 startups takes off | https://www.thehindu.com/news/cities/Hyderabad/aic-t-hub-spacetech-accelerator-cohort-with-17-startups-takes-off/article69788033.ece
Articles about Nirdharya Lab India Private Limited
- A Ground-Based Simulator in Bareilly Preps Experiments for Space — The two-year-old startup's end-to-end platform aims to let researchers validate experiments on Earth before booking a slot in orbit, starting with Indian biotech and pharma.